New drug combo trial offers hope for advanced colon cancer patients
Disease control
Not yet recruiting
This study is testing a new drug called AMT-676 in combination with standard chemotherapy drugs for people with advanced colorectal cancer that cannot be surgically removed. The main goals are to see if the combination is safe, what side effects occur, and whether it helps shrink…
Phase: PHASE2 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC